Aethlon Medical (AEMD) Competitors $0.58 +0.15 (+33.83%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends AEMD vs. MBOT, NRXS, NEPH, LUCY, IINN, LFWD, MHUA, SSKN, LYRA, and PYPDShould you be buying Aethlon Medical stock or one of its competitors? The main competitors of Aethlon Medical include Microbot Medical (MBOT), NeurAxis (NRXS), Nephros (NEPH), Innovative Eyewear (LUCY), Inspira Technologies Oxy B.H.N. (IINN), ReWalk Robotics (LFWD), Meihua International Medical Technologies (MHUA), STRATA Skin Sciences (SSKN), Lyra Therapeutics (LYRA), and PolyPid (PYPD). These companies are all part of the "medical equipment" industry. Aethlon Medical vs. Microbot Medical NeurAxis Nephros Innovative Eyewear Inspira Technologies Oxy B.H.N. ReWalk Robotics Meihua International Medical Technologies STRATA Skin Sciences Lyra Therapeutics PolyPid Aethlon Medical (NASDAQ:AEMD) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, community ranking, profitability and institutional ownership. Is AEMD or MBOT more profitable? Aethlon Medical's return on equity of -160.36% beat Microbot Medical's return on equity.Company Net Margins Return on Equity Return on Assets Aethlon MedicalN/A -160.36% -115.74% Microbot Medical N/A -218.30%-158.17% Which has more volatility and risk, AEMD or MBOT? Aethlon Medical has a beta of 1.79, indicating that its stock price is 79% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.62, indicating that its stock price is 62% more volatile than the S&P 500. Does the media favor AEMD or MBOT? In the previous week, Aethlon Medical had 2 more articles in the media than Microbot Medical. MarketBeat recorded 2 mentions for Aethlon Medical and 0 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 1.30 beat Aethlon Medical's score of 0.32 indicating that Microbot Medical is being referred to more favorably in the news media. Company Overall Sentiment Aethlon Medical Neutral Microbot Medical Positive Which has better valuation & earnings, AEMD or MBOT? Microbot Medical has lower revenue, but higher earnings than Aethlon Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAethlon Medical$570K14.21-$12.21M-$2.82-0.21Microbot MedicalN/AN/A-$10.74M-$0.80-1.21 Does the MarketBeat Community prefer AEMD or MBOT? Microbot Medical received 129 more outperform votes than Aethlon Medical when rated by MarketBeat users. Likewise, 70.67% of users gave Microbot Medical an outperform vote while only 51.78% of users gave Aethlon Medical an outperform vote. CompanyUnderperformOutperformAethlon MedicalOutperform Votes21851.78% Underperform Votes20348.22% Microbot MedicalOutperform Votes34770.67% Underperform Votes14429.33% Do institutionals and insiders believe in AEMD or MBOT? 2.0% of Aethlon Medical shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 1.1% of Aethlon Medical shares are owned by insiders. Comparatively, 10.5% of Microbot Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts recommend AEMD or MBOT? Aethlon Medical presently has a consensus price target of $7.00, indicating a potential upside of 1,106.90%. Microbot Medical has a consensus price target of $7.00, indicating a potential upside of 621.65%. Given Aethlon Medical's higher probable upside, equities research analysts clearly believe Aethlon Medical is more favorable than Microbot Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Microbot Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAethlon Medical and Microbot Medical tied by winning 7 of the 14 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Aethlon Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEMD vs. The Competition Export to ExcelMetricAethlon MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.10M$4.34B$5.13B$9.07BDividend YieldN/A44.57%5.08%4.23%P/E Ratio-0.2125.3789.5817.17Price / Sales14.2145.951,116.12116.95Price / CashN/A43.4542.8237.86Price / Book0.267.094.774.78Net Income-$12.21M$13.64M$120.15M$225.60M7 Day Performance61.74%-2.93%-1.92%-1.23%1 Month Performance48.99%0.28%11.47%3.36%1 Year Performance-69.31%40.76%30.54%16.60% Aethlon Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEMDAethlon Medical3.0781 of 5 stars$0.58+33.8%$7.00+1,106.9%-68.6%$8.10M$570,000.00-0.2110Analyst ForecastNews CoverageGap UpHigh Trading VolumeMBOTMicrobot Medical2.6578 of 5 stars$1.01+0.9%$7.00+593.5%-28.7%$17.09MN/A-1.2520NRXSNeurAxisN/A$2.43-2.0%N/A+13.7%$16.96M$2.46M-1.3519Gap DownNEPHNephros1.6925 of 5 stars$1.54-0.6%$5.00+224.7%-50.0%$16.24M$13.55M-17.2230Positive NewsLUCYInnovative Eyewear1.7088 of 5 stars$6.39+4.6%$20.00+213.0%-34.1%$15.60M$1.56M-0.639Positive NewsIINNInspira Technologies Oxy B.H.N.0.3085 of 5 stars$1.12-4.3%N/A-21.2%$14.14MN/A0.0020Gap DownLFWDReWalk Robotics3.3589 of 5 stars$1.54-6.7%$13.00+744.2%N/A$13.56M$25.00M-0.6260Positive NewsGap UpHigh Trading VolumeMHUAMeihua International Medical Technologies0.6851 of 5 stars$0.51+2.3%N/A-87.5%$12.85M$94.25M0.00620Gap DownSSKNSTRATA Skin Sciences1.0262 of 5 stars$2.99-0.3%N/A-54.7%$12.47M$32.68M-1.11120LYRALyra Therapeutics2.4114 of 5 stars$0.19+2.2%$4.50+2,311.6%-96.0%$12.21M$1.47M-0.1250Gap DownPYPDPolyPid2.3344 of 5 stars$2.44-6.5%$12.00+391.8%-15.5%$11.71MN/A-0.3080Analyst RevisionHigh Trading Volume Related Companies and Tools Related Companies MBOT Alternatives NRXS Alternatives NEPH Alternatives LUCY Alternatives IINN Alternatives LFWD Alternatives MHUA Alternatives SSKN Alternatives LYRA Alternatives PYPD Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AEMD) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aethlon Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.